Terms: = Lymphoma AND HOXA9, HOX1, 3205, ENSG00000078399, HOX1G, P31269
64 results:
1. MEIS inhibitors reduce the viability of primary leukemia cells and Stem cells by inducing apoptosis.
Meriç N; Albayrak E; Gülbaş Z; Kocabaş F
Leuk Lymphoma; 2024 Feb; 65(2):187-198. PubMed ID: 37902585
[TBL] [Abstract] [Full Text] [Related]
2. A comprehensive landscape of transcription profiles and data resources for human leukemia.
Luo M; Miao YR; Ke YJ; Guo AY; Zhang Q
Blood Adv; 2023 Jul; 7(14):3435-3449. PubMed ID: 36595475
[TBL] [Abstract] [Full Text] [Related]
3. Panobinostat (LBH589) increase survival in adult xenografic model of acute lymphoblastic leukemia with t(4;11) but promotes antagonistic effects in combination with MTX and 6MP.
Moreno DA; Junior HLR; Laranjeira ABA; Cruzeiro GAV; Borges KS; Salomão KB; Ramalho FS; Yunes JA; Silva CLA; Rego EM; Scrideli CA; Tone LG
Med Oncol; 2022 Sep; 39(12):216. PubMed ID: 36175721
[TBL] [Abstract] [Full Text] [Related]
4. MiR-27a downregulates 14-3-3θ, RUNX1, AF4, and MLL-AF4, crucial drivers of blast transformation in t(4;11) leukemia cells.
Fioretti T; Zanobio M; Raia M; Errichiello S; Izzo B; Cattaneo F; Ammendola R; Cevenini A; Esposito G
Cell Biochem Funct; 2022 Oct; 40(7):706-717. PubMed ID: 35981137
[TBL] [Abstract] [Full Text] [Related]
5. Downregulation of hsa-miR-548d-3p and overexpression of hoxa9 in diffuse large B-cell lymphoma patients and the risk of R-CHOP chemotherapy resistance and disease progression.
Ting CY; Tan SY; Gan GG; Zain SM; Pung YF; Ong DB; Bee PC
Int J Lab Hematol; 2022 Oct; 44(5):907-917. PubMed ID: 35830966
[TBL] [Abstract] [Full Text] [Related]
6. RNA-binding proteins as drivers of AML and novel therapeutic targets.
Qin T; Cheng Y; Wang X
Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic analysis of patients with T-ALL identifies poor outcomes and a hypomethylating agent-responsive subgroup.
Touzart A; Mayakonda A; Smith C; Hey J; Toth R; Cieslak A; Andrieu GP; Tran Quang C; Latiri M; Ghysdael J; Spicuglia S; Dombret H; Ifrah N; Macintyre E; Lutsik P; Boissel N; Plass C; Asnafi V
Sci Transl Med; 2021 May; 13(595):. PubMed ID: 34039737
[TBL] [Abstract] [Full Text] [Related]
8. Nuclear FGFR2 Interacts with the MLL-AF4 Oncogenic Chimera and Positively Regulates
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Cattaneo F; Ammendola R; Esposito G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33924850
[TBL] [Abstract] [Full Text] [Related]
9. Stem cell characteristics promote aggressiveness of diffuse large B-cell lymphoma.
Chang KC; Chen RY; Wang YC; Hung LY; Medeiros LJ; Chen YP; Chen TY; Yang JC; Chiang PM
Sci Rep; 2020 Dec; 10(1):21342. PubMed ID: 33288848
[TBL] [Abstract] [Full Text] [Related]
10. hoxa9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia.
Symeonidou V; Ottersbach K
Exp Hematol; 2021 Jan; 93():38-43.e5. PubMed ID: 33069783
[TBL] [Abstract] [Full Text] [Related]
11. PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis.
Lim JT; Singh N; Leuvano LA; Calvert VS; Petricoin EF; Teachey DT; Lock RB; Padi M; Kraft AS; Padi SKR
Mol Cancer Ther; 2020 Sep; 19(9):1809-1821. PubMed ID: 32753387
[TBL] [Abstract] [Full Text] [Related]
12. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia.
Salik B; Yi H; Hassan N; Santiappillai N; Vick B; Connerty P; Duly A; Trahair T; Woo AJ; Beck D; Liu T; Spiekermann K; Jeremias I; Wang J; Kavallaris M; Haber M; Norris MD; Liebermann DA; D'Andrea RJ; Murriel C; Wang JY
Cancer Cell; 2020 Aug; 38(2):263-278.e6. PubMed ID: 32559496
[TBL] [Abstract] [Full Text] [Related]
13. Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia.
Loftus JP; Yahiaoui A; Brown PA; Niswander LM; Bagashev A; Wang M; Schauf A; Tannheimer S; Tasian SK
Haematologica; 2021 Apr; 106(4):1067-1078. PubMed ID: 32414848
[TBL] [Abstract] [Full Text] [Related]
14. Crosstalk between 14-3-3θ and AF4 enhances MLL-AF4 activity and promotes leukemia cell proliferation.
Fioretti T; Cevenini A; Zanobio M; Raia M; Sarnataro D; Salvatore F; Esposito G
Cell Oncol (Dordr); 2019 Dec; 42(6):829-845. PubMed ID: 31493143
[TBL] [Abstract] [Full Text] [Related]
15. Long-term effectiveness and cost-effectiveness of an 18-week supervised exercise program in patients treated with autologous stem cell transplantation: results from the EXIST study.
van Dongen JM; Persoon S; Jongeneel G; Bosmans JE; Kersten MJ; Brug J; Nollet F; Chinapaw MJM; Buffart LM
J Cancer Surviv; 2019 Aug; 13(4):558-569. PubMed ID: 31286387
[TBL] [Abstract] [Full Text] [Related]
16. Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib.
Kok CH; Yeung DT; Lu L; Watkins DB; Leclercq TM; Dang P; Saunders VA; Reynolds J; White DL; Hughes TP
Blood Adv; 2019 May; 3(10):1610-1621. PubMed ID: 31126916
[TBL] [Abstract] [Full Text] [Related]
17. JMJD1C-mediated metabolic dysregulation contributes to hoxa9-dependent leukemogenesis.
Lynch JR; Salik B; Connerty P; Vick B; Leung H; Pijning A; Jeremias I; Spiekermann K; Trahair T; Liu T; Haber M; Norris MD; Woo AJ; Hogg P; Wang J; Wang JY
Leukemia; 2019 Jun; 33(6):1400-1410. PubMed ID: 30622285
[TBL] [Abstract] [Full Text] [Related]
18. An integrated transcriptome analysis in T-cell acute lymphoblastic leukemia links DNA methylation subgroups to dysregulated TAL1 and ANTP homeobox gene expression.
Haider Z; Larsson P; Landfors M; Köhn L; Schmiegelow K; Flaegstad T; Kanerva J; Heyman M; Hultdin M; Degerman S
Cancer Med; 2019 Jan; 8(1):311-324. PubMed ID: 30575306
[TBL] [Abstract] [Full Text] [Related]
19. Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4
Bardini M; Trentin L; Rizzo F; Vieri M; Savino AM; Garrido Castro P; Fazio G; Van Roon EHJ; Kerstjens M; Smithers N; Prinjha RK; Te Kronnie G; Basso G; Stam RW; Pieters R; Biondi A; Cazzaniga G
Mol Cancer Ther; 2018 Aug; 17(8):1705-1716. PubMed ID: 29748211
[No Abstract] [Full Text] [Related]
20.
Trissal MC; Wong TN; Yao JC; Ramaswamy R; Kuo I; Baty J; Sun Y; Jih G; Parikh N; Berrien-Elliott MM; Fehniger TA; Ley TJ; Maillard I; Reddy PR; Link DC
Cancer Res; 2018 Jul; 78(13):3510-3521. PubMed ID: 29724719
[TBL] [Abstract] [Full Text] [Related]
[Next]
